Abstract:

This study analyzed anthropometric indicators such as body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), and body mass index (BMI), in addition to measuring indicators such as Vaspin and Visfatin levels. A link between obesity and the metabolic and hormonal changes that affect overall health. The study sample included 90 men aged 25 to 45 years old. They were divided into five groups based on their body mass index (BMI). The first (control) group included 18 men of normal weight, while the second group included 18 overweight men. The third group included 18 men with class I obesity, and the fourth group included 18 men with class II obesity. The fifth group included 18 men with a history of obesity. Participants with chronic diseases or conditions that also affect metabolic processes were excluded. The study showed that Vaspin and Visfatin levels increased inversely with increasing BMI, suggesting a role for these proteins and hormones in the metabolic effects associated with obesity. The study concluded that using body mass index (BMI) alone to assess health risks may be insufficient, as it does not reflect the distribution of body fat. Therefore, it is preferable to use a combination of anthropometric indicators such as waist circumference, WHR, WHtR, and body fat percentage to provide a comprehensive assessment of health risks associated with obesity. The results also indicate that individuals with increased waist circumference and WHR are more susceptible to heart disease and diabetes.

References:

[1]. Coll, P. P., Phu, S., Hajjar, S. H., Kirk, B., Duque, G., Taxel, P., 2021, The prevention of osteoporosis and sarcopenia in older adults. Journal of the American Geriatrics Society, 69(5), 1388-1398, doi:10.1111/jgs.17043.

[2]. Mohammed, S. A., Sarhat, E. R., 2024, Evaluation of Serum Eta Protein, Sclerostin, and Calcitonin Level in Arthritis Patients on Vitamin D Therapy. Pharmacognosy Journal, 16(2), doi:10.5530/pj.2024.16.67.

[3]. Obied, M. M., Sarhat, E. R., 2024, The Role of Vitamin D-Binding Protein, and Procalcitonin in Patients with Arthritis on Vitamin D. Pharmacognosy Journal, 16(2), doi:10.5530/pj.2024.16.68.

[4]. Sarhat, E. R., Alddin Ibrahim, S. K., 2020, Assessment of Serum Levels of Fetuin-A, Lipocalin-2, Interleukin-18, and C-Reactive Protein in Rheumatoid Arthritis Patients: A Biochemical Study. Cellular and Molecular Science, 22(55), 1-9.

[5]. Hofsø, D., Hillestad, T. O. W., Halvorsen, E., Fatima, F., Johnson, L. K., Lindberg, M., Hjelmesæth, J., 2021, Bone mineral density and turnover after sleeve gastrectomy and gastric bypass: a randomized controlled trial (Oseberg). The Journal of Clinical Endocrinology and Metabolism, 106(2), 501-511, doi:10.1210/clinem/dgaa808.

[6]. Aliyu, N. A., Aliyu, A. B., Jibril, A. M., Bello, Z. I., 2025, Obesity and Risk of Knee Osteoarthritis: A Case-Control Hospital-based Study of 372 Patients. Texila International Journal of Public Health, 2025, 13(1):45-51, doi: 10.21522/TIJPH.2013.13.01.Art006.

[7]. Barbalho, S. M., Tofano, R. J., Oliveira, M. B. D., Quesada, K. R., Barion, M. R., Akuri, M. C., Bechara, M. D., 2019, HDL-C and non-HDL-C levels are associated with anthropometric and biochemical parameters. Jornal vascular brasileiro, 18, e20180109, doi:10.1590/1677-5449.180109.

[8]. Elbanna, I. A., Karthik, N. P., Selvankumar, T., 2025, The Impact of Dietary Cholesterol on LDL Cholesterol Levels in Adults: A Short-Term Observational Study. Texila International Journal of Public Health, 2025, 13(1):458-467, doi: 10.21522/TIJPH.2013.13.01.Art045.

[9]. Cui, R., Zhou, L., Li, Z., Li, Q., Qi, Z., Zhang, J., 2016, Assessment risk of osteoporosis in Chinese people: relationship among body mass index, serum lipid profiles, blood glucose, and bone mineral density. Clinical interventions in aging, 887-895, doi:10.2147/CIA.S103845.

[10]. Al-Barwani, R., Sarhat, E., 2024, Breast cancer-modulated omentin and vaspin plasma levels. Georgian Medical News, (347), 66-69.

[11]. Sarhat, E. R., Rmaid, Z. J., Jabir, T. H., 2020, Changes of salivary interleukine17, Apelin, Omentin and Vaspin levels in normal subjects and diabetic patients with chronic periodontitis. Ann Trop Med & Pub Health, 23(1), S404, doi:10.36295/ASRO.2020.23118.

[12]. Jarjees, Z., Sarhat, E., 2024, Assessment of osteopontin, sclerostin, and osteocalcin levels in patients with hypothyroidism on medical therapy. Georgian Medical News, (347), 131-135.

[13]. Hamad, M. S., Sarhat, E. R., Sarhat, T. R., Abass, K. S., 2021, Impact of serum Adropin and Irisin in Iraqi patients with congestive heart failure. PJMH S, 15(2), 497-499.

[14]. Curtis, E. M., Moon, R. J., Harvey, N. C., Cooper, C., 2017, Reprint of: the impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. International journal of orthopaedic and trauma nursing, 26, 7-17, doi:10.1016/j.ijotn.2017.04.004.

[15]. Kim, J., Ha, J., Jeong, C., Lee, J., Lim, Y., Jo, K., Baek, K. H., 2023, Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study. Osteoporosis International, 34(1), 119-128, doi:10.1007/s00198-022-06571-z.

[16]. Shen, Y., Huang, X., Wu, J., Lin, X., Zhou, X., Zhu, Z., Shan, P. F., 2022, The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019. Frontiers in Endocrinology, 13, 882241, doi:10.3389/fendo.2022.882241.

[17]. Handisurya, A., Riedl, M., Vila, G., Maier, C., Clodi, M., Prikoszovich, T., Luger, A., 2018. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obesity Surgery, 28(5), 1303–1310, doi:10.1007/s11695-017-3010-3

[18]. Giardullo, A. L., Schiavo, L., Pilone, V., Barbarisi, A., 2021, Vaspin: A Way to Understand the Connection between Obesity, Diabetes, and Cardiovascular Diseases. International Journal of Environmental Research and Public Health, 18(4), 1821, doi:10.3390/ijerph18041821

[19]. Youn, B. S., Kloting, N., Kratzsch, J., Lee, N., Park, J. W., Song, E. S., Bluher, M., 2008, Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes, 57(2), 372-377, doi:10.2337/db07-1045.

 [20]. Heiker, J. T., 2014, Vaspin (serpinA12) in obesity, insulin resistance, and inflammation. Journal of Peptide Science, 20(5), 299-306, doi:10.1002/psc.2621.

[21]. Hida, K., Wada, J., Eguchi, J., Zhang, H., Baba, M., Seida, A., Kanwar, Y. S., 2005, Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proceedings of the national academy of sciences, 102(30), 10610-10615, doi:10.1073/pnas.0504703102